|
|
|
- Lead compound identification
- Lead compound optimization
- Rapid assay through-put
- Specific lead compound assay development
- Product differentiation (wide variety of methods)
- Improved protocol subject identification and selection
- Dose and schedule optimization
- Identification of potential side effects (especially hematologic)
- New drug indications
- Individual patient monitoring for dose (post FDA approval)
|
|
|
|
|